探究肝移植患者MELD评分与术后营养状态的关系
Exploring the Relationship between MELD Score and Postoperative Nutritional Status in Liver Transplant Patients
DOI: 10.12677/acm.2025.152513, PDF,    科研立项经费支持
作者: 刘连腾, 李一龙, 杨乃昕:山东第一医科大学临床医学院,山东 济南;李自强*:山东第一医科大学第一附属医院(千佛山医院)外科学,山东 济南
关键词: 肝移植MELD评分腰大肌身高指数少肌症营养状况Liver Transplantation MELD Score Lumbar Muscle Height Index Sarcopenia Nutritional Status
摘要: 目的:探讨肝移植患者终末期肝病模型(MELD)与术后营养状态的关系,以期为临床提供更精确的评估工具和管理策略。方法:收集2019年1月至2023年7月于本中心接受肝移植术的99例患者的临床资料,使用腰大肌身高指数对患者术后生存及营养状态进行预测;依据病因、MELD评分进行亚组分析。结果:少肌症组和无少肌症组在年龄、白蛋白水平、L3-PMI以及生存时间上有统计学意义(p < 0.05)。MELD评分亚组中,肝恶性肿瘤患者L3-PMI为A组3.51 ± 0.75、B组2.47 ± 0.76、C组2.76 ± 0.96,酒精性肝硬化患者L3-PMI为A组3.13 ± 0.45、B组2.25 ± 0.28、C组3.01 ± 1.92,A与B组之间比较差异有统计学意义(p < 0.05),其余组间无统计学意义;乙肝肝硬化失代偿患者L3-PMI为A组3.74 ± 0.83、B组2.88 ± 0.53、C组2.09 ± 0.36,三组组间比较均有统计学意义(p < 0.05)。结论:L3-PMI可以有效评价患者营养状况和术后生存状态;MELD评分与术后营养状况存在显著的相关性,高MELD评分的患者往往术后营养状况较低,容易发生营养障碍。
Abstract: Objective: To explore the relationship between end-stage liver disease (MELD) model and postoperative nutritional status in liver transplant patients, in order to provide more accurate assessment tools and management strategies for clinical practice. Method: Clinical data of 99 patients who underwent liver transplantation at our center from January 2019 to July 2023 were collected, and the lumbar muscle height index was used to predict the postoperative survival and nutritional status of the patients; Perform subgroup analysis based on etiology and MELD score. Result: There were statistically significant differences (p < 0.05) in age, albumin levels, L3-PMI, and survival time between the sarcopenia group and the non sarcopenia group. In the MELD scoring subgroups, the L3-PMI of patients with liver malignant tumors was 3.51 ± 0.75 in group A, 2.47 ± 0.76 in group B, and 2.76 ± 0.96 in group C. The L3-PMI of patients with alcoholic cirrhosis was 3.13 ± 0.45 in group A, 2.25 ± 0.28 in group B, and 3.01 ± 1.92 in group C. There was a statistically significant difference between group A and group B (p < 0.05), while there was no statistically significant difference between the other groups; The L3-PMI of decompensated patients with hepatitis B cirrhosis was 3.74 ± 0.83 in group A, 2.88 ± 0.53 in group B, and 2.09 ± 0.36 in group C. The comparison among the three groups was statistically significant (p < 0.05). Conclusion: L3-PMI can effectively evaluate the nutritional status and postoperative survival status of patients; There is a significant correlation between MELD score and postoperative nutritional status. Patients with high MELD scores often have lower postoperative nutritional status and are prone to nutritional disorders.
文章引用:刘连腾, 李一龙, 杨乃昕, 李自强. 探究肝移植患者MELD评分与术后营养状态的关系[J]. 临床医学进展, 2025, 15(2): 1588-1596. https://doi.org/10.12677/acm.2025.152513

参考文献

[1] Shi, J., Cao, M., Wang, Y., Bai, F., Lei, L., Peng, J., et al. (2020) Is It Possible to Halve the Incidence of Liver Cancer in China by 2050? International Journal of Cancer, 148, 1051-1065. [Google Scholar] [CrossRef] [PubMed]
[2] Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C.J., Vignat, J., et al. (2022) Global Burden of Primary Liver Cancer in 2020 and Predictions to 2040. Journal of Hepatology, 77, 1598-1606. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, W., Xiao, P., Xu, H., Niu, J. and Gao, Y. (2019) Growing Burden of Alcoholic Liver Disease in China: A Review. World Journal of Gastroenterology, 25, 1445-1456. [Google Scholar] [CrossRef] [PubMed]
[4] Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., et al. (2019) EASL Clinical Practice Guidelines on Nutrition in Chronic Liver Disease. Journal of Hepatology, 70, 172-193. [Google Scholar] [CrossRef] [PubMed]
[5] Biggins, S.W., Angeli, P., Garcia-Tsao, G., Ginès, P., Ling, S.C., Nadim, M.K., et al. (2021) Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 74, 1014-1048. [Google Scholar] [CrossRef] [PubMed]
[6] Yoshiji, H., Nagoshi, S., Akahane, T., Asaoka, Y., Ueno, Y., Ogawa, K., et al. (2021) Evidence-Based Clinical Practice Guidelines for Liver Cirrhosis 2020. Journal of Gastroenterology, 56, 593-619. [Google Scholar] [CrossRef] [PubMed]
[7] 郑树森, 董家鸿, 窦科峰, 等. 中国肝癌肝移植临床实践指南(2021版) [J]. 中华移植杂志(电子版), 2021, 15(6): 321-328.
[8] Bischoff, S.C., Bernal, W., Dasarathy, S., Merli, M., Plank, L.D., Schütz, T., et al. (2022) ESPEN Practical Guideline: Clinical Nutrition in Liver Disease. Nutrición Hospitalaria, 39, 434-472. [Google Scholar] [CrossRef] [PubMed]
[9] Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., et al. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48, 601-601. [Google Scholar] [CrossRef] [PubMed]
[10] Duong, N., Sadowski, B. and Rangnekar, A.S. (2021) The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes. Clinical Liver Disease, 17, 271-276. [Google Scholar] [CrossRef] [PubMed]
[11] Estruch, R., Nicolás, J.M., Villegas, E., Junqué, A. and Urbano-Márquez, A. (1993) Relationship between Ethanol-Related Diseases and Nutritional Status in Chronically Alcoholic Men. Alcohol and Alcoholism, 28, 543-550.
[12] Dharancy, S., Boitard, J., Decaens, T., Sergent, G., Boleslawski, E., Duvoux, C., et al. (2007) Comparison of Two Techniques of Transarterial Chemoembolization before Liver Transplantation for Hepatocellular Carcinoma: A Case-Control Study. Liver Transplantation, 13, 665-671. [Google Scholar] [CrossRef] [PubMed]
[13] Amini, B., Boyle, S.P., Boutin, R.D. and Lenchik, L. (2019) Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review. The Journals of Gerontology: Series A, 74, 1671-1678. [Google Scholar] [CrossRef] [PubMed]
[14] van der Kroft, G., Fritsch, S.J.J., Rensen, S.S., Wigger, S., Stoppe, C., Lambertz, A., et al. (2021) Is Sarcopenia a Risk Factor for Reduced Diaphragm Function Following Hepatic Resection? A Study Protocol for a Prospective Observational Study. BMJ Open, 11, e053148. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, E.H., Kim, K.W., Shin, Y., Lee, J., Ko, Y., Kim, Y., et al. (2020) Reference Data and T-Scores of Lumbar Skeletal Muscle Area and Its Skeletal Muscle Indices Measured by CT Scan in a Healthy Korean Population. The Journals of Gerontology: Series A, 76, 265-271. [Google Scholar] [CrossRef] [PubMed]
[16] 刘鹏. 术前少肌症和全身免疫炎症指数预测非肌层浸润性膀胱癌卡介苗灌注疗效[D]: [硕士学位论文]. 济南: 山东大学, 2023.
[17] Tantai, X., Liu, Y., Yeo, Y.H., Praktiknjo, M., Mauro, E., Hamaguchi, Y., et al. (2022) Effect of Sarcopenia on Survival in Patients with Cirrhosis: A Meta-Analysis. Journal of Hepatology, 76, 588-599. [Google Scholar] [CrossRef] [PubMed]
[18] 王然, 张永国, 李谦谦, 等. 第三腰椎腰大肌面积指数对肝硬化患者营养状态及预后评估价值[J]. 临床军医杂志, 2022, 50(7): 729-732.
[19] 陈木兴, 王少扬. 肠道菌群失调在乙型肝炎相关慢加急性肝衰竭发病机制中的作用[J]. 临床肝胆病杂志, 2019, 35(3): 665-668.
[20] 王十锦. 慢加急性肝衰竭小鼠模型建立及临床队列研究[D]: [硕士学位论文]. 上海: 上海交通大学, 2018.
[21] 曾艳霞, 袁群芳, 程秋霞, 等. 营养支持对合并营养风险肝癌手术患者康复效果的影响[J]. 肝脏, 2019, 24(2): 201-203.
[22] Yang, S., Zhang, L., Jin, Q., Wang, J., Ma, D., Gao, J., et al. (2023) Meld-Sarcopenia Score and Skeletal Muscle Density Predicts Short-Term Readmission of Patients with Hepatic Encephalopathy. European Journal of Radiology, 169, Article 111178. [Google Scholar] [CrossRef] [PubMed]